bioSyntagma
Colleen Ziegler is a founding member of bioSyntagma, leveraging experiences performing advanced molecular analysis in research and clinical settings. She holds a BS in Genetics, Cell, and Developmental Biology from Arizona State University. Her proficiency in molecular techniques have allowed her to hold positions in multiple labs at Arizona State University, studying topics as diverse as inflammatory cell death and single cell analysis of Barrett’s Esophagus progression. She also has previous experience working in a CLIA laboratory performing blood screening for pathogens on the nation’s blood supply.
This person is not in any offices
bioSyntagma
bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each person’s cancer.